39 results found.

Melanoma (Skin) Clinical Trial using gene expression analysis; polymerase chain reaction; polymorphism analysis; matrix-assisted laser desorption/ionization time of flight mass spectrometry; medical chart review

Case Comprehensive Cancer Center - Recruiting N/A or older.
- Identification of Genomic Lesions Promoting Nodal Metastasis in Malignant Melanoma.
gene expression analysis; polymerase chain reaction; polymorphism analysis; matrix-assisted laser desorption/ionization time of flight mass spectrometry; medical chart review

Metastatic Melanoma, or Skin Cancer Clinical Trial using Cyclophosphamide; Fludarabine; Young TIL

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 70 years.
- A Pilot Study of the Administration of Young Tumor Infiltrating Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen in Metastatic Melanoma.
Cyclophosphamide; Fludarabine; Young TIL

Skin Cancer Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting 10 years or older.
- In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin.

Prostate Cancer Clinical Trial using Muscadine Plus Grape Skin Extract

Johns Hopkins University - Recruiting 18 years or older.
- Phase I/II Study of Safety and Efficacy of Muscadine Plus (MPX) in Men With Prostate Cancer: a Randomized,Double-blind,Placebo Controlled Study of the Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer.
Muscadine Plus Grape Skin Extract

Actinic Keratosis, or Squamous Cell Carcinoma Clinical Trial using Superficial shave biopsy

Northwestern University - Recruiting 18 years to 89 years.
- Nanocytology Evaluation of Epidermal Cells to Assess Risk of Squamous Cell Carcinoma and Field Cancerization in High Risk Patients.
Superficial shave biopsy

Brain and Central Nervous System Tumors, Intraocular Melanoma, Lu Clinical Trial using DNA analysis; immunologic technique; pharmacological study; iodine I 131 monoclonal antibody 3F8; 131I-3F8

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms.
DNA analysis; immunologic technique; pharmacological study; iodine I 131 monoclonal antibody 3F8; 131I-3F8

Colorectal Cancer, Dermatologic Complications, Lung Cancer, or Th Clinical Trial using assessment of therapy complications; psychosocial assessment and care; quality-of-life assessment

Southwest Oncology Group - Recruiting N/A or older.
- S1013: A Prospective Study of Epidermal Growth Factor Receptor (HER-1/EGFR) Inhibitor-Induced Dermatologic Toxicity: Validation of the Functional Assessment of Cancer Therapy-EGFRI 18(FACT-EGFRI 18) Questionnaire for EGFRI-Induced Skin Toxicities.
assessment of therapy complications; psychosocial assessment and care; quality-of-life assessment

Cancer, or Advanced Solid Tumors Clinical Trial using Sunitinib; Sorafenib; Erlotinib; Everolimus; Lapatinib; Dasatinib; Pazopanib; Vemurafenib; tumor biopsy; skin biopsy (optional)

VU University Medical Center - Recruiting 18 years or older.
- Pilot Study on the Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies..
Sunitinib; Sorafenib; Erlotinib; Everolimus; Lapatinib; Dasatinib; Pazopanib; Vemurafenib; tumor biopsy; skin biopsy (optional)

Metastatic Melanoma, or Skin Cancer Clinical Trial using Cyclophosphamide; Fludarabine; Tumor Infiltrating Lymphocytes; IL-15

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 66 years.
- A Phase I/II Study of IL-15 Administration Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen and Autologous Lymphocyte Transfer in Metastatic Melanoma.
Cyclophosphamide; Fludarabine; Tumor Infiltrating Lymphocytes; IL-15

Metastatic Melanoma, or Skin Cancer Clinical Trial using Aldesleukin; Cyclophosphamide; Fludarabine; Young Tumor Infiltrating Lymphocytes; 1200 Gy Irradiation

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 66 years.
- Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI).
Aldesleukin; Cyclophosphamide; Fludarabine; Young Tumor Infiltrating Lymphocytes; 1200 Gy Irradiation

Breast Cancer, Healthy Volunteer, or Prostate Cancer Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 90 years.
- An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin.

Invasive Breast Cancer Clinical Trial using Eucerin; Mometasone Furoate 0.1%

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation:A Randomized Trial, Double Blind Trial.
Eucerin; Mometasone Furoate 0.1%

Melanoma (Skin) Clinical Trial using MART-1; NY-ESO-1; gp100:209-217(210M); gp100:280-288(288V); Montanide ISA 51 VG; BMS-936558

H. Lee Moffitt Cancer Center and Research Institute - Recruiting 16 years or older.
- A Pilot Trial of a Vaccine Combining Multiple Class I Peptides and Montanide ISA 51 VG With Escalating Doses of Anti-PD-1 Antibody BMS-936558 for Patients With Unresectable Stages III/IV Melanoma.
MART-1; NY-ESO-1; gp100:209-217(210M); gp100:280-288(288V); Montanide ISA 51 VG; BMS-936558

Psoriasis Vulgaris, or Psoriasis Clinical Trial using tofacitinib ointment 20 mg/g; tofacitinib ointment 10 mg/g; placebo ointment (vehicle)

Pfizer - Recruiting 18 years or older.
- A Phase 2b, Multi-Site, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
tofacitinib ointment 20 mg/g; tofacitinib ointment 10 mg/g; placebo ointment (vehicle)

Psoriasis Clinical Trial using CP-690,550

Pfizer - Recruiting 18 years or older.
- A Phase 3, Multi-Site, Open-Label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis.
CP-690,550

Actinic Keratosis Clinical Trial using ingenol mebutate

LEO Pharma - Recruiting 18 years or older.
- Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis.
ingenol mebutate

Cancer, HIV Infection, or Skin Disease Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI) Center for Cancer Research (CCR) Clinical Protocols.

Colorectal Cancer, or Non-Small Cell Lung Cancer Clinical Trial

ICORG- All Ireland Cooperative Oncology Research Group - Recruiting 18 years or older.
- Correlation of Single Nucleotide Polymorphism (SNP) Profile of Domain III of EGFR to Skin and/or Eye Toxicity and Disease Response to Treatment With Cetuximab or Panitumumab - SNP and Cetuximab or Panitumumab Response.

Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma (Skin), o Clinical Trial

ICORG- All Ireland Cooperative Oncology Research Group - Recruiting N/A or older.
- Collaborative Project on Potential Serum Markers for Malignant Melanoma, Metastatic Breast, Advanced Lung Pancreatic Carcinoma and Colorectal Cancer.

Metastatic Gastrointestinal Carcinoid Tumor, Pulmonary Carcinoid Clinical Trial using pazopanib hydrochloride; placebo; quality-of-life assessment; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Prospective Randomized Phase II Trial of Pazopanib (NSC # 737754, IND 75648) Versus Placebo in Patients With Progressive Carcinoid Tumors.
pazopanib hydrochloride; placebo; quality-of-life assessment; laboratory biomarker analysis

Skin Cancer of the Head and Neck Clinical Trial

University of Florida - Recruiting 18 years or older.
- A Clinical Outcomes Protocol of Photon/Proton Beam Radiation Therapy for Carcinoma of the Skin of the Head and Neck With Perineural Invasion.

Skin Rash, or Lung Cancer Clinical Trial using Tetracycline

Instituto Nacional de Cancerologia de Mexico - Recruiting 18 years or older.
- Phase II, Open-label, Single Blind, Randomised Clinical Trial With Tetracycline as a Prophylaxis for Rash and Dermatological Recommendations Versus Dermatological Recommendations in Patients With NSCLC Receiving Treatment With BIBW 2992.
Tetracycline

Psoriasis Clinical Trial using M518101

Maruho North America Inc. - Recruiting 18 years or older.
- An Open-label, Multi-center, Long-term Study to Evaluate the Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis.
M518101

Non-melanomatous Skin Cancer Clinical Trial using aminolevulinic acid hydrochloride

National Cancer Institute (NCI) - Recruiting 30 years or older.
- Investigation of the Effectiveness of Non-Coherent Blue Light in Intralesional Photodynamic of Basal Cell Carcinoma.
aminolevulinic acid hydrochloride

Melanoma (Skin) Clinical Trial using cisplatin; sorafenib tosylate; tamoxifen citrate; adjuvant therapy

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase II Pilot Trial of Sorafenib, Tamoxifen and Cisplatin as Adjuvant Therapy for Patients With Stage III Malignant Melanoma.
cisplatin; sorafenib tosylate; tamoxifen citrate; adjuvant therapy

Melanoma (Skin) Clinical Trial using bevacizumab; oxaliplatin; sorafenib tosylate

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase I/II Trial of Nexavar, Avastin and Eloxatin in Patients With Metastatic Malignant Melanoma.
bevacizumab; oxaliplatin; sorafenib tosylate

Melanoma, or Skin Cancer Clinical Trial using Panobinostat; Ipilimumab

H. Lee Moffitt Cancer Center and Research Institute - Recruiting 18 years or older.
- A Phase 1 Study of HDAC Inhibitor Panobinostat (LBH 589) Administered in Combination With Ipilimumab in Subjects With Unresectable Stage III or Stage IV Melanoma.
Panobinostat; Ipilimumab

Ras-wildtype Colorectal Cancer Clinical Trial using Erythromycin; Doxycycline

AIO-Studien-gGmbH - Recruiting 18 years or older.
- Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of Quality of Life in Patients With Ras-wildtype Colorectal Cancer.
Erythromycin; Doxycycline

CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma, Lympho Clinical Trial using SGN-35

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Phase II Trial of Brentuximab Vedotin (SGN-35) at Dose of 1.8 mg/kg IV Every 3 Weeks in Patients With CD30-positive Lymphoproliferative Disorders (Cutaneous Anaplastic Large T-cell Lymphoma (ALCL), Mycosis Fungoides, and Extensive Lymphomatoid Papulosis (LyP).
SGN-35

Recurrent Neuroendocrine Carcinoma of the Skin, or Stage IV Neuro Clinical Trial using radiation therapy; recombinant interferon beta; MCPyV TAg-specific polyclonal autologous CD8-positive T cell vaccine; aldesleukin; laboratory biomarker analysis

Fred Hutchinson Cancer Research Center - Recruiting 18 years or older.
- Study to Evaluate Cellular Adoptive Immunotherapy Using Polyclonal Autologous CD8+ Antigen-Specific T Cells for Metastatic Merkel Cell Carcinoma.
radiation therapy; recombinant interferon beta; MCPyV TAg-specific polyclonal autologous CD8-positive T cell vaccine; aldesleukin; laboratory biomarker analysis

Colorectal Cancer, or Head and Neck Cancer Clinical Trial using Doxycycline; Hydrocortisone 1% cream; Sunscreen; Moisturizer; Clindamycin; Medrol-dose pack (Steroid)

James Graham Brown Cancer Center - Recruiting 18 years or older.
- Preemptive Therapy Study of Cetuximab(Erbituxr)Induced Skin Rash Using Doxycycline, Sunscreen, Hydrocortisone and Moisturizer in Colorectal and Head and Neck Cancer Patients.
Doxycycline; Hydrocortisone 1% cream; Sunscreen; Moisturizer; Clindamycin; Medrol-dose pack (Steroid)

Plaque Psoriasis Clinical Trial using Calcitriol 3 mcg/g ointment

Galderma - Recruiting 2 years to 12 years.
- Pharmacokinetics and Pharmacodynamics of Calcitriol 3 Mcg/g Ointment Applied Twice Daily for 14 Days Under Conditions of Maximal Use in Pediatric Subjects (2 to 12 Years of Age) With Plaque Psoriasis.
Calcitriol 3 mcg/g ointment

Glioma, Brain Cancer, Brain Tumor, Glioblastoma Multiforme, or Hi Clinical Trial using Dendritic Cell Vaccine; Tumor Lysate; Imiquimod; Punch Biopsy of the Skin; Leukapheresis

University of Miami Sylvester Comprehensive Cancer Center - Recruiting 1 year to 30 years.
- A Phase I Study of Dendritic Cell Vaccine Therapy With In Situ Maturation for Pediatric Brain Tumors.
Dendritic Cell Vaccine; Tumor Lysate; Imiquimod; Punch Biopsy of the Skin; Leukapheresis

Melanoma (Skin) Clinical Trial using gene expression analysis; mutation analysis; diagnostic laboratory biomarker analysis; immunohistochemistry staining method; sentinel lymph node biopsy

National Cancer Institute (NCI) - Recruiting N/A or older.
- A Retrospective Case-Control Study of Melanoma Patients Who Have Undergone Sentinel Lymph Node Biopsy.
gene expression analysis; mutation analysis; diagnostic laboratory biomarker analysis; immunohistochemistry staining method; sentinel lymph node biopsy

Head and Neck Cancer Clinical Trial using bandage skin Hydrosorb; Biafiner

Centre Francois Baclesse - Recruiting 18 years to 69 years.
- Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy.
bandage skin Hydrosorb; Biafiner

Breast Cancer, or Dermatitis Clinical Trial using 3M Cavilon No Sting Barrier Film

Lawson Health Research Institute - Recruiting 18 years to 80 years.
- Phase III Randomized Pair Comparison of a Barrier Film vs. Standard Skin Care in Preventing Radiation Dermatitis in Women With Breast Cancer Receiving Adjuvant Radiation Therapy.
3M Cavilon No Sting Barrier Film

Mucosal Lentiginous Melanoma, or Acral Lentiginous Malignant Mela Clinical Trial using nilotinib

Institute of Cancer Research, United Kingdom - Recruiting 18 years or older.
- A Phase II Trial of Nilotinib in the Treatment of Patients With c-KIT Mutated Advanced Acral and Mucosal Melanoma.
nilotinib

in Situ Breast Cancer, or Invasive Breast Cancer Clinical Trial using Insertion of suction drain(s) following mastectomy; Adaptive skin sutures.

National Institute of Oncology, Hungary - Recruiting N/A to 75 years.
- Optimal Wound Care After Simplex or Modified Radical Mastectomy With or Without Axillary Lymphadenectomy Placement of a Drain Versus the Use of Adaptive Skin Sutures; a Prospective Randomised Study.
Insertion of suction drain(s) following mastectomy; Adaptive skin sutures.

Stroke, or Hypertension Clinical Trial using Educational intervention for diet and physical activity; Educational message on skin cancer awareness

University of Michigan - Recruiting 18 years or older.
- Stroke Health and Risk Education (SHARE).
Educational intervention for diet and physical activity; Educational message on skin cancer awareness